Algeria: Antidiabetic Drugs Produced in Tizi Ouzou to Be Exported Abroad From 2016

Algiers — The chief executive officer of Danish laboratories Novo Nordisk, Lars Rebien Sorens, has announced that antidiabetic drugs produced by the plant of Tizi Ouzou (103-km east of Algiers), as part of a partnership between Algeria and Denmark, will be exported abroad from 2016.

Lars, speaking with Minister of Health, Population and Hospital Reform Abdelmalek Boudiaf, stressed the importance Novo Nordisk laboratories attached to cooperation with Algerian pharmaceutical group Saidal to cover domestic market needs in Insulin and to extend exports in the future, announcing that exports of drugs manufactured in Tizi-Ouzou plant will begin in 2016.

...

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.